Oregon · 2025 Regular Session · Bill
SB 533: Relating to restrictions on 340B covered entities.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 533 is a bill introduced in the Oregon Senate on January 13, 2025. According to its official title, it concerns: Relating to restrictions on 340B covered entities. Primary sponsor: Deb Patterson (Democratic), Rob Nosse (Democratic), James Manning (Democratic). Most recent recorded action (June 27, 2025): At President's desk upon adjournment.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Creates a civil penalty for drug manufactures that require certain entities to submit utilization review data as a condition of acquiring, delivering or dispensing 340B drugs.
Sponsors
Sponsors by party (alphabetical): Democratic 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Deb Patterson | Primary sponsor | Democratic | Senate | 10 |
| Rob Nosse | Primary sponsor | Democratic | House | 42 |
| James Manning | Primary sponsor | Democratic | Senate | 7 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- At President's desk upon adjournment.
- Work Session held.
- Public Hearing held.
- Referred to Health Care.
- Introduction and first reading. Referred to President's desk.